Resource hub

Beyond the Purpose: Dr Linda McGoldrick on culture, storytelling and what makes a board excellent

In this episode of Beyond the Purpose, hosts James Cox and Jay Webster are joined by Dr Linda McGoldrick, a global healthcare and life sciences leader whose…

BioTalent launches Advisory Board to shape the future of life sciences talent

BioTalent, has launched an Advisory Board, bringing together senior leaders from across biotech, pharma services, MedTech and life sciences investment.

Where AI-driven drug discovery is heading: Murat Tunaboylu's three generations of tech bio

On the latest episode of Beyond the Purpose, Murat Tunaboylu, CEO and co-founder of Antiverse, set out a framework for how AI-driven drug discovery companies…

Beyond the Purpose: Murat Tunaboylu on funding, resilience and building for purpose

In episode two of Beyond the Purpose, hosts James Cox and Jay Webster sit down with Murat Tunaboylu, CEO and co-founder of Antiverse, who brings almost a…

Beyond the Purpose: A new podcast from BioX

BioX, BioTalent's executive search arm, launches Beyond the Purpose Pdcast

BIO-Europe 2026

BioTalent is an Association Partner of BIO-Europe 2026, from 9-11th November. Save 10% off your ticket using the code BioTalent10.

Building the future: Recruiting for foundation models, GenAI and LLMs in biology

Sam Francis, Associate Director at BioTalent, on the skills and talent strategies reshaping foundation model, GenAI and LLM hiring in biology.

Case study: Placing a specialist R&D engineer for a leading spinal implants company

How BioTalent filled a niche R&D Engineer role for a San Diego spinal implants company in under three weeks, from submission to start date.

Beyond the Purpose: Martin Stenfeldt on why traction determines what scales

In the first episode of Beyond the Purpose, hosts James Cox and Jay Webster sit down with Martin Stenfeldt, CEO at UNEEG Medical, who brings deep experience…

The impact of Generative AI on life sciences professionals

Nicholas Boyle polled his network on generative AI's day-to-day impact here's what life sciences professionals said.

From batch to bioreactor: How Industry 4.0 is reinventing CDMO flexibility

Why flexibility is the new CDMO differentiator, and how digital twins, real-time analytics and AI are reshaping biomanufacturing talent needs.

The Science of Talent in Biopharma at the Festival of Biologics

This session from Dr Jason Beckwith explores how predictive, finance-grade talent analytics can measure and optimise human performance, linking Talent…